Page last updated: 2024-11-11

24,25-dihydroxyvitamin d2

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

24,25-dihydroxyvitamin D2: metabolite of vitamin D2; RN given refers to (3beta,5Z,7E,22E)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9547251
SCHEMBL ID1249402
MeSH IDM0090862

Synonyms (8)

Synonym
LMST03010048
(5z,7e,22e)-(3s,24r)-9,10-seco-5,7,10(19),22-ergostatetraene-3,24,25-triol
(24r)-24,25-dihydroxyvitamin d2 / (24r)-24,25-dihydroxyergocalciferol
24,25-dihydroxyvitamin d2
SCHEMBL1249402
mfcd22124601
(24r)-24,25-dihydroxyvitamin d2/(24r)-24,25-dihydroxyergocalciferol
(e,3r,6r)-6-[(1r,3as,4e,7ar)-4-[(2z)-2-[(5s)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-1-yl]-2,3-dimethylhept-4-ene-2,3-diol

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"We evaluated the long-term bioavailability and metabolism of a single po or intramuscular (im) high dose of ergocalciferol (D₂) or D₃."( Long-term bioavailability after a single oral or intramuscular administration of 600,000 IU of ergocalciferol or cholecalciferol: implications for treatment and prophylaxis.
Carlucci, L; Cipriani, C; McMahon, DJ; Minisola, S; Nieddu, L; Pepe, J; Piemonte, S; Romagnoli, E; Russo, S; Singh, R, 2013
)
0.39
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (27)

TimeframeStudies, This Drug (%)All Drugs %
pre-199018 (66.67)18.7374
1990's3 (11.11)18.2507
2000's0 (0.00)29.6817
2010's6 (22.22)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (7.14%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (7.14%)4.05%
Observational1 (3.57%)0.25%
Other23 (82.14%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]